Annovis Bio Announces Positive FDA Notice For Buntanetap Pha

/PRNewswire/ -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases,...

Related Keywords

Berwyn , Pennsylvania , United States , Marial Maccecchini , Nic Johnson , Hoehn Yahr , Annovis Bio , Exchange Commission , Prnewswire Annovis Bio Inc , Linkedin , Twitter , Annovis Bio Inc , Russo Partners , Company Alzheimer , Participant Global Impression , Clinical Global Impression , Annual Report , Investor Contact , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,